Evotec SE American Depositary Shares (EVO) is a publicly traded Healthcare sector company. As of May 21, 2026, EVO trades at $2.90 with a market cap of $973.22M and a P/E ratio of 0.00. EVO moved +2.70% today. Year to date, EVO is -10.97%; over the trailing twelve months it is -30.22%. Its 52-week range spans $2.31 to $5.64. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces EVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Evotec Places €116.1M Convertible Bonds Due 2033 at 2.625% Interest: Evotec placed €116.1 million of senior unsecured convertible bonds due 2033, bearing interest at 2.625% and repaid at 110% of principal for a 3.882% yield. Bonds convert at €6.5313 (37.5% premium) with an effective €7.1844 price at maturity to fund its Project Horizon transformation program.
| Metric | Value |
|---|---|
| Price | $2.90 |
| Market Cap | $973.22M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.07% |
| 52-Week High | $5.64 |
| 52-Week Low | $2.31 |
| Volume | 40 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover EVO: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.